Sarcopedia

MalignantSoft tissue

Undifferentiated Pleomorphic Sarcoma

Synonyms: UPS, Malignant Fibrous histiocytoma (historical), MFH

Diagnosis of exclusion - must rule out specific sarcoma subtypes

Quick Facts

Behaviour

Malignant

Category

Soft tissue

Grade

High

Synonyms

  • UPS
  • Malignant Fibrous histiocytoma (historical)
  • MFH

Category

Soft tissue

Behaviour

Malignant

Grade

High

Gender

Male

Tissue of Origin

No identifiable cell line

Epidemiology

  • One of the most common soft tissue sarcomas in adults
  • Peak incidence 50-70 years
  • Can be radiation-associated

Clinical Features

  • Rapidly enlarging deep soft tissue mass
  • Often >5cm at presentation
  • Pain in 50%
  • May present with metastatic disease (lung most common)

Location

  • Lower extremity (especially thigh)
  • Upper extremity
  • Retroperitoneum
  • Trunk

Imaging

  • MRI: heterogeneous solid mass with areas of necrosis/haemorrhage
  • Enhancement is heterogeneous
  • Often deep to fascia

Pathology

  • Diagnosis of exclusion - High-grade pleomorphic sarcoma NOS
  • No identifiable line of differentiation
  • Marked pleomorphism, atypical mitoses
  • Must exclude dedifferentiated liposarcoma (MDM2-), leiomyosarcoma, etc.

Genetics

  • Complex karyotype, no specific recurrent translocation
  • Must exclude MDM2 amplification (dedifferentiated liposarcoma)

Treatment

  • Wide surgical excision with adequate margins
  • Neoadjuvant/adjuvant radiotherapy for high-grade, deep, >5cm tumours
  • Consider adjuvant chemotherapy (doxorubicin-based) for high-risk tumours

Prognosis

  • 5-year survival 50-65%
  • Size >5cm, deep location, high grade = adverse factors
  • Metastasis rate 30-40% (predominantly lung)
  • Local recurrence 20-30%

Key Points

  • Diagnosis of exclusion - must rule out specific sarcoma subtypes
  • Previously called Malignant Fibrous histiocytoma (MFH)
  • Always exclude MDM2 amplification to rule out dedifferentiated liposarcoma
  • Managed with wide excision ± radiotherapy ± chemotherapy

Workup - Blood Tests

  • FBC, U&E, LFTs, Bone profile (if Bone) - baseline and pre-chemotherapy
  • LDH - elevated in advanced disease

Workup - Local Imaging

MRI primary site with gadolinium

Workup - Biopsy

Core needle biopsy at sarcoma centre

Workup - Staging

  • CT chest/abdomen/pelvis
  • PET-CT

Workup - Other

MDM discussion at a sarcoma centre

Follow-up Summary

  1. Soft Tissue Tumours - Localised Extremity - Intermediate and High Grade

    Radiotherapy patients

    monitor irradiated field for late effects at each review

Medical disclaimer

The content on Sarcopedia is for educational and informational purposes only and does not constitute medical advice. It is not intended to be a substitute for professional medical diagnosis or treatment. Always consult with a qualified physician regarding any health concerns or before starting any new treatment. Reliance on any information provided on this site is solely at your own risk.